| Trial ID: | L0944 |
| Source ID: | NCT00586716
|
| Associated Drug: |
Intravenous Immune Globulin
|
| Title: |
Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00586716/results
|
| Conditions: |
End Stage Renal Disease
|
| Interventions: |
DRUG: intravenous immune globulin
|
| Outcome Measures: |
Primary: Elimination of Donor Specific Antibodies, 1 year | Secondary: Negative B and T Cell Crossmatch, 1year
|
| Sponsor/Collaborators: |
Sponsor: Loma Linda University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
22
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-11
|
| Completion Date: |
2009-10
|
| Results First Posted: |
2016-06-06
|
| Last Update Posted: |
2017-01-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00586716
|
